Navigation Links
assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires
Date:10/27/2008

Five years ago, a large biotech company began collecting ePRO (electronic patient reported outcomes) data using .assisTek's proven tablet system in clinical trials around the world. Recently, assistek's financial team calculated the costs of using the assisTek system compared to what it would have cost if the client had used traditional paper questionnaires. The results showed that assisTek's ePRO data collection saved the client $1.6 million over paper questionnaires over 10 studies.

Scottsdale, AZ (PRWEB) October 27, 2008 -- Five years ago, a large biotech company began collecting ePRO (electronic patient reported outcomes) data using assisTek's proven tablet system in clinical trials around the world. Recently, assistek's financial team calculated the costs of using the assisTek system compared to what it would have cost if the client had used traditional paper questionnaires. The results showed that assisTek's ePRO data collection saved the client $1.6 million over paper questionnaires over 10 studies.

The results were significant and wide ranging. assisTek's ePRO tablets saved the customer money in 7 out of the 10 studies, with 1 study saving over $1,000,000 alone. In addition, the customer benefited from much more rapid access to significantly higher quality data than would be possible with paper-based questionnaires. The customer also enjoyed assisTek's industry leading online study management system, which provides real time management reports, which also would have not been possible with paper questionnaires.

"All of assisTek's ePRO data collection products deliver patient reported outcomes data in clinical trials that is consistently more than 99% complete," said Joy Hebert, Chief Operating Officer. "This means that clients can significantly reduce queries, and the significant time and labor traditionally required for resolving them. In addition, our unique system reduces workload by more 90%."

For more information about assisTek's ePRO systems or to schedule a free no-obligation demonstration, contact Reinet Marneweck at reinet.marneweck@assistek.com.

About .assisTek:
.assisTek is the global leader in ePRO systems and has revolutionized the process of collecting patient-reported outcomes in clinical trials by helping sites collect the data electronically and systematically through large 9 inch tablet touch-screens, iPhones, mobile PDAs, and on the web.
.assisTek's ePRO products are the most advanced in the industry. The .assisTek team has the deepest knowledge and experience in the industry having served more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents.

.assisTek, formerly Assist Technologies, can be found on the web at assisTek.com.

# # #

Read the full story at http://www.prweb.com/releases/ePRO/clinical-trials/prweb1520734.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Cost-Effective Anti-Fatigue Solution from MEGAComfort Now Available for Employees in Biotech and Research Industries
2. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
3. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
4. Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
5. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
6. UCLA and biotech company develop first blood test to measure key hormone that regulates iron
7. InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
8. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
9. The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health
10. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
11. Pulmo BioTech Inc. Announces Possibility of MRI Application for PulmoBind
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: